NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Munafa technical analysis Sarepta Therapeutics, Inc. SRPT technical analysis buy or sell

Munafa technical analysis Sarepta Therapeutics, Inc. SRPT technical analysis buy or sell Analysis of Sarepta Therapeutics, Inc. SRPT to buy or sell for Daily, weekly or monthly

Quick Chart Bull Charts Forecast Tomorrow Price Targets View Analysis

Sarepta Therapeutics, Inc. SRPT Daily Analysis to buy or sell

As per my analysis of Sarepta Therapeutics, Inc. SRPT, 12 day returns for Sarepta Therapeutics, Inc. SRPT have been negative, with total returns of -0.079999999999998, which is -0.36% with investment starting at 22.20.
An investment of 100,000 bucks in Sarepta Therapeutics, Inc. would have become 99640 bucks today.

Sarepta Therapeutics, Inc. SRPT moves in a range of 0.5 points on a day to day basis. This means that a total of approx 0.5 plus points of returns can be expected in a bullish day, and a total of 0.5 minus points can be expected in a bearish day.
This is about 2.26% of returns per day.

Sarepta Therapeutics, Inc. Munafa analysis, looking for Trend and BUY or SELL opportunities.

Stock is in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Sarepta Therapeutics, Inc. SRPT at this time.

It appears as if Sarepta Therapeutics, Inc. SRPT gave a large move recently.

Stock of Sarepta Therapeutics, Inc. (SRPT) is trading above an important moving average line, but it crossed this line recently, which means that it could show a small or a large fall soon enough depending on its trend.

My analysis of Sarepta Therapeutics, Inc. is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 22.4 as stoploss in an intra day sell trade for a target of 21.6. However, stock will show a bullish move above 22.4.

You can find more Price Targets here or Forecast here for Shortterm, Midterm, and Longterm

Daily Candle Stick analysis of Sarepta Therapeutics, Inc. SRPT

Candle stick analysis of Sarepta Therapeutics, Inc. as on 26 Fri Dec 2025 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 2.5 HC: 1.3 LC: 1.2 OC: 1.5

Sarepta Therapeutics, Inc. is moving towards a low expiry

Candle stick analysis of Sarepta Therapeutics, Inc. as on 24 Wed Dec 2025 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 2.9 HC: 0.6 LC: 2.3 OC: 2.3

Sarepta Therapeutics, Inc. is moving towards a high expiry

Candle stick analysis of Sarepta Therapeutics, Inc. as on 23 Tue Dec 2025 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 6.8 HC: 2.4 LC: 4.3 OC: 6.3

Sarepta Therapeutics, Inc. is moving towards a high expiry

Candle stick analysis of Sarepta Therapeutics, Inc. as on 22 Mon Dec 2025 is showing a red candle, which means that the sellers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 3.2 HC: 1.5 LC: 1.7 OC: 1.4

Sarepta Therapeutics, Inc. is moving towards a high expiry

Candle stick analysis of Sarepta Therapeutics, Inc. as on 19 Fri Dec 2025 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 5.9 HC: 2.2 LC: 3.6 OC: 4.8

Sarepta Therapeutics, Inc. is moving towards a high expiry

Sarepta Therapeutics, Inc. SRPT Weekly Analysis to buy or sell

As per my analysis of Sarepta Therapeutics, Inc. SRPT, 12 week returns for Sarepta Therapeutics, Inc. SRPT have been negative, with total returns of -0.36, which is -1.6% with investment starting at 22.48.
An investment of 100,000 bucks in Sarepta Therapeutics, Inc. would have become 98400 bucks today.

Sarepta Therapeutics, Inc. SRPT moves in a range of 1.2 points on a week to week basis. This means that a total of approx 1.2 plus points of returns can be expected in a bullish week, and a total of 1.2 minus points can be expected in a bearish week.
This is about 5.42% of returns per week.

Weekly Candle Stick analysis of Sarepta Therapeutics, Inc. SRPT

Candle stick analysis of Sarepta Therapeutics, Inc. as on 26 Fri Dec 2025 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 8 HC: 1.8 LC: 6 OC: 6

Sarepta Therapeutics, Inc. is moving towards a high expiry

Candle stick analysis of Sarepta Therapeutics, Inc. as on 19 Fri Dec 2025 is showing a red candle, which means that the sellers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 14.1 HC: 9.3 LC: 4.3 OC: 5

Sarepta Therapeutics, Inc. is moving towards a low expiry

Candle stick analysis of Sarepta Therapeutics, Inc. as on 12 Fri Dec 2025 is showing a red candle, which means that the sellers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 10.1 HC: 6.1 LC: 3.7 OC: 1.4

Sarepta Therapeutics, Inc. is moving towards a low expiry

Candle stick analysis of Sarepta Therapeutics, Inc. as on 05 Fri Dec 2025 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 18.7 HC: 3.3 LC: 14.9 OC: 10.4

Sarepta Therapeutics, Inc. is moving towards a high expiry

Candle stick analysis of Sarepta Therapeutics, Inc. as on 28 Fri Nov 2025 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 23 HC: 0.2 LC: 22.8 OC: 21.1

Sarepta Therapeutics, Inc. is moving towards a high expiry

Sarepta Therapeutics, Inc. SRPT Monthly Analysis to buy or sell

As per my analysis of Sarepta Therapeutics, Inc. SRPT, 12 month returns for Sarepta Therapeutics, Inc. SRPT have been negative, with total returns of -91.6, which is -80.55% with investment starting at 113.72.
An investment of 100,000 bucks in Sarepta Therapeutics, Inc. would have become 19450 bucks today.

Sarepta Therapeutics, Inc. SRPT moves in a range of 10.2 points on a month to month basis. This means that a total of approx 10.2 plus points of returns can be expected in a bullish month, and a total of 10.2 minus points can be expected in a bearish month.
This is about 46.11% of returns per month.

Monthly Candle Stick analysis of Sarepta Therapeutics, Inc. SRPT

Candle stick analysis of Sarepta Therapeutics, Inc. as on 26 Fri Dec 2025 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 18.7 HC: 4 LC: 14.2 OC: 10.4

Sarepta Therapeutics, Inc. is moving towards a high expiry

Candle stick analysis of Sarepta Therapeutics, Inc. as on 28 Fri Nov 2025 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 41.8 HC: 0.2 LC: 41.5 OC: 40.3

Sarepta Therapeutics, Inc. is moving towards a high expiry

Candle stick analysis of Sarepta Therapeutics, Inc. as on 31 Fri Oct 2025 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 39.6 HC: 5.5 LC: 32.4 OC: 39.4

Sarepta Therapeutics, Inc. is moving towards a high expiry

Candle stick analysis of Sarepta Therapeutics, Inc. as on 26 Fri Sep 2025 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 16.4 HC: 6.8 LC: 9 OC: 8.6

Sarepta Therapeutics, Inc. is moving towards a high expiry

Candle stick analysis of Sarepta Therapeutics, Inc. as on 29 Fri Aug 2025 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Sarepta Therapeutics, Inc. are:
HL: 89.1 HC: 21.4 LC: 55.8 OC: 88.6

Sarepta Therapeutics, Inc. is moving towards a high expiry

Share on: WhatsApp Facebook Tweet